IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?

Feier ChenMeng QuFeng ZhangZhenyu TanQinghua XiaBrett D HamblyShisan Bob BaoKun Tao

Published in: BMC cancer (2020)

IL-36α or IL-36γ are reliable biomarkers in predicting the prognosis of CRC during the later or early stages of the disease, respectively. Combining IL-36α plus IL-36γ appears to more accurately predict the postoperative prognosis of CRC patients. Our data may be useful in the management of CRC.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
patients undergoing
prognostic factors
machine learning
electronic health record
peritoneal dialysis
patient reported outcomes
big data
data analysis